BILLERICA, Mass.,
Jan. 3, 2017/PRNewswire/ --
Bruker Corporation(NASDAQ: BRKR) announced today it will present at the 35thannual
J.P. Morgan Healthcare Conferencein
San Francisco.
Frank Laukien, Chairman, President & CEO and
Tony Mattacchione, Senior Vice President and CFO will present on behalf of the company on
Monday, January 9th, 2017 at
8:00 AM Pacific Time.
A live audio webcast of the presentation will be available on the Investor section of the Company's Web site athttp://ir.bruker.com. A replay of the presentation will be posted on the
Bruker Corporationwebsite after the event and will be available for 30 days following the presentation.
About
Bruker Corporation
For more than 50 years,
Bruker越是加大使科学家能够取得突破eries and develop new applications that improve the quality of human life.
Bruker'shigh-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers,
Brukeris enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit://www.energie2point0.com.
Contact:
Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300384750.html
SOURCE
Bruker Corporation